Cell MedX Corp. (OTC:CMXC)
Health Care/Life Sciences • Pharmaceuticals
CIK 1493712
Company
Cell MedX Corp. is a biotech company, which engages in the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness. Its products include microcurrent therapy and eBalance systems. The company was founded on March 19, 2010 and is headquartered in Carson City, NV.
Address
820 - 1130 Pender Street
West Vancouver, British Columbia V6E 4A4
820 - 1130 Pender Street
West Vancouver, British Columbia V6E 4A4
Employees
None
None
Stock Info
Key Executives
Board Of Directors
Chairman George Adams PhD |
Chief Executive Officer & Director David M Jeffs |
CFO, Secretary, Treasurer & Director Yanika S Silina CPA |
Director Amir Vahabzadeh |
Independent Director Joao da Costa |
Director Dwayne Yaretz |
SEC filings
Date | Form | Event |
---|---|---|
29 Aug, 2024 | 10-K | |
15 Apr, 2024 | 10-Q | |
4 Apr, 2024 | 8-K | |
26 Mar, 2024 | D | |
19 Mar, 2024 | 8-K | |
6 Mar, 2024 | DEF 14C | |
28 Feb, 2024 | 8-K | |
22 Feb, 2024 | PRE 14C | |
22 Feb, 2024 | 144 | |
16 Jan, 2024 | 10-Q | |
10 Jan, 2024 | 4 | |
9 Jan, 2024 | 3 | |
9 Jan, 2024 | 4 | |
9 Jan, 2024 | 4 | |
9 Jan, 2024 | 4 | |
9 Jan, 2024 | 4 | |
9 Jan, 2024 | 3 | |
19 Dec, 2023 | 8-K | CEO Change |
27 Nov, 2023 | 8-K | |
13 Nov, 2023 | 8-K | |
16 Oct, 2023 | 10-Q | |
7 Sep, 2023 | SC 13D | |
1 Sep, 2023 | 10-K | |
29 Aug, 2023 | NT 10-K | |
29 Jun, 2023 | 10-Q | |
19 May, 2023 | 10-Q | |
19 Apr, 2023 | 10-Q | |
7 Apr, 2023 | 10-K | |
18 Oct, 2022 | 8-K | |
29 Aug, 2022 | NT 10-K | |
18 May, 2022 | 3 | |
27 Apr, 2022 | 8-K | CEO Change |
11 Apr, 2022 | 10-Q | |
8 Apr, 2022 | 4 | |
11 Feb, 2022 | 4 | |
8 Feb, 2022 | 4 | |
12 Jan, 2022 | 10-Q | |
7 Jan, 2022 | 4 | |
3 Jan, 2022 | 4 | |
21 Dec, 2021 | 4 | |
17 Dec, 2021 | 4 | |
29 Nov, 2021 | 4 | |
14 Oct, 2021 | 10-Q | |
14 Oct, 2021 | 424B3 | |
12 Oct, 2021 | 424B3 | |
14 Sep, 2021 | 4 | |
10 Sep, 2021 | 4 | |
30 Aug, 2021 | 10-K | |
4 Aug, 2021 | 4 | |
2 Aug, 2021 | 4 | |
2 Aug, 2021 | D | |
29 Jul, 2021 | 4 | |
26 Jul, 2021 | 4 | |
8 Jul, 2021 | D | |
6 Jul, 2021 | 4 | |
28 Jun, 2021 | 4 | |
25 Jun, 2021 | 4 | |
17 Jun, 2021 | 4 | |
15 Jun, 2021 | 4 | |
1 Jun, 2021 | 4 | |
27 May, 2021 | 424B3 | |
26 May, 2021 | 8-K | |
30 Apr, 2021 | 4 | |
26 Apr, 2021 | 4 | |
21 Apr, 2021 | 4 | |
19 Apr, 2021 | 4 | |
9 Apr, 2021 | 424B3 | |
9 Apr, 2021 | 10-Q | |
7 Apr, 2021 | 4 | |
31 Mar, 2021 | 4 | |
31 Mar, 2021 | 4 | |
31 Mar, 2021 | 4 | |
15 Mar, 2021 | 424B3 | |
12 Mar, 2021 | EFFECT | |
10 Mar, 2021 | CORRESP | |
9 Mar, 2021 | UPLOAD | |
4 Mar, 2021 | S-1 | |
16 Feb, 2021 | 4 | |
14 Jan, 2021 | 10-Q |
Last update:2024-03-08 12:08:10.549177
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.